GeneralConnection.com ➔ Dictionary
Dictionary Search

narcoleptic

Synonyms

Adjective

1. hypersomnia

Noun

1. sick person

2. diseased person, sufferer, soporific

3. hypnotic

Usage
Individualizing Narcolepsy Care: Real-World Oxybate Outcomes - Psychiatric Times
Patients With Narcolepsy Experience Significant Burden of Disease - AJMC
Sleep Disorder Drugs That Target Brain Circuitry Show Promise - Bloomberg
Takeda’s new study data for oveporexton shows improvements in narcolepsy type 1 - PMLiVE
Alkermes reports positive phase 2 results for narcolepsy drug - Investing.com
Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study Of Alixorexton In Adults With Narcolepsy Type 2 At Sleep 2026 - TradingView
Alkermes (ALKS) Advances Narcolepsy Treatment with Positive Phas - GuruFocus
Alixorexton for the Treatment of Narcolepsy Type 2: Insights From SLEEP 2026 - Psychiatric Times
Oveporexton Improves REM Sleep Architecture and Sleep-Related Symptoms in Phase 3 Narcolepsy Type 1 Studies - NeurologyLive
Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026 - Yahoo Finance
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia - PR Newswire
Late-Breaking Sleep Data: Narcolepsy Drug Efficacy and Weekly Sleep Trends - AJMC
Human narcolepsy is linked to degeneration of both locus coeruleus and hypocretin neurons - Nature
FDA approves Wakix for cataplexy in pediatric narcolepsy - American Academy of Sleep Medicine | AASM
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1 - Business Wire
Alkermes stock jumps as narcolepsy drug hits trial goals - Investing.com
Real-World Outcomes With Sodium Oxybate in Narcolepsy - Psychiatric Times
Takeda (TSE:4502) Unveils Phase 3 Wins In Narcolepsy And Psoriasis - Yahoo Finance
Healthy Sleep Improves Outcomes in Cardiovascular Health for OSA, Narcolepsy - AJMC
Oveporexton Improves Daily Function, Cognition, and Nighttime Sleep in Narcolepsy Type 1 - Psychiatric Times
Takeda’s oveporexton shows broader benefits in Phase III narcolepsy studies - The Pharma Letter
Alkermes Granted Orphan Drug Designations for Alixorexton in US, Europe - Sleep Review
FDA grants breakthrough designation for narcolepsy drug alixorexton - American Academy of Sleep Medicine | AASM
Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe - BioSpace
8 Ways to Recharge and Boost Energy With Narcolepsy - Everyday Health
Severe narcolepsy found to damage a second brain region - UCLA Health
Ex-recruiting director for U Hawai’i football sues over narcolepsy discrimination - The Independent
Novel Patient-Reported Outcome Instrument Developed to Measure Functional Impacts of Narcolepsy - Docwire News
Takeda's Narcolepsy Drug May Redefine Care and Seize a New Market - BriefGlance
A conversation exploring the newest discovery in narcolepsy research, with sleep researcher Jerome Siegel, Ph.D. - Managed Healthcare Executive
Why Narcolepsy Is Often Missed—and How to Spot It - Psychiatry Online
Why do 'sleep attacks' happen? Study points to an autoimmune trigger in narcolepsy - Medical Xpress
Oveporexton Improves Cognition in Narcolepsy Type 1 - Psychiatric Times
NeuroVoices: Jerome Siegel, PhD, on Locus Coeruleus Neuron Loss as a Key Pathologic Feature of Narcolepsy - NeurologyLive
ASPIRE Survey Study Results: New Insights on Patients With Narcolepsy & Idiopathic Hypersomnia - Psychiatric Times
Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications for precision sleep medicine - Frontiers
Takeda Pharmaceutical Company Limited Presents Additional Results from Two Pivotal Studies Showing Oveporexton Improves Daily Function, Cognition, and Nighttime Sleep for People with Narcolepsy Type 1 - marketscreener.com
Diagnosing narcolepsy: What to know about polysomnograms and multiple sleep latency tests - Mayo Clinic Press
Video: High-Dose Low-Sodium Oxybate for Narcolepsy—AAN 2026 Expert Insights - Neurology Advisor
Evaluating Pitolisant and Other Pharmacologic Treatment Options for Narcolepsy - Psychiatric Times
First orexin agonists address root cause of narcolepsy - Nature
DUET Trial: Low-Sodium Oxybate Significantly Consolidates Nighttime Sleep Architecture in Narcolepsy - AJMC
Alkermes receives transatlantic orphan drug designations for alixorexton - grafa.com
'Conclusive Evidence That Narcolepsy Type 1 Is a Result of the Body’s Own Immune System' - Sleep Review
EISAI TO BEGIN ENROLLING PHASE 2 STUDY IN PATIENTS WITH NARCOLEPSY - PR Newswire
Axsome pushes back generic entry for narcolepsy drug until 2040 - Endpoints News
Alkermes Launches Phase 3 Brilliance Program for Alixorexton in Narcolepsy - NeurologyLive
Multidisciplinary Approaches to Long-Term Narcolepsy Care - Psychiatric Times
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion - The New York Times
Your guide to narcolepsy treatments and side effects, according to a sleep medicine expert - Mayo Clinic Press
Narcolepsy Type 2 in an Adolescent With Childhood Obstructive Sleep Apnea and Coexisting Absence Epilepsy: A Case Report - Cureus
Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal - statnews.com
Narcolepsy Drug Shows Promise for Boosting Cognition - Psychiatrist.com
Assessing DEA Scheduling and Emerging Therapies in Narcolepsy - Psychiatric Times
New AAN Poster Presentation on Alixorexton for Narcolepsy Type 1: Improvement in Disease Severity, Cognitive Functioning, and Fatigue - Psychiatric Times
Video: How to Diagnose Narcolepsy and Avoid Common Pitfalls – With Expert Insights - Psychiatry Advisor
Alkermes (ALKS) wins orphan drug designations in U.S. and Europe for alixorexton - Stock Titan
Reboxetine Reduces Overall Narcolepsy Symptom Severity and Improves EDS, Mood-Related Symptoms - Pharmacy Times
Phase 3 Brilliance Studies Initiated on Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 - Psychiatric Times
How Common is Narcolepsy? Prevalence, Symptoms, Causes, More - Healthline
Novel First-in-Class Drug Tied to Improved Cognition in Narcolepsy - Medscape
Narcolepsy can impact your child’s memory — Here are the best tips to help keep on track - Mayo Clinic Press
Narcolepsy Treatment Considerations in Pediatric Patients - Psychiatric Times
Navigating Diagnostic Challenges in Narcolepsy - Psychiatric Times
Lilly to buy narcolepsy drug developer for $6.3 billion - C&EN
Alkermes Starts Phase 3 Orexin Trials As Narcolepsy Story Builds - Yahoo Finance
FDA Approves Pitolisant for Treatment of Cataplexy in Pediatric Narcolepsy - Pharmacy Times
Alkermes’ alixorexton secures FDA and EC orphan designations - Pharmaceutical Business review -
Alkermes to Present Sustained Efficacy Data for Alixorexton in Narcolepsy Type 1 - Sleep Review
MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and More - Psychiatry Online
Narcolepsy in Children: Causes, Symptoms, Treatment - WebMD
Reviewing the Prevalence and Underdiagnosis of Narcolepsy - NeurologyLive
How Alixorexton could transform narcolepsy treatment - American Society for Biochemistry and Molecular Biology
Reviewing the Prevalence and Underdiagnosis of Narcolepsy - Psychiatric Times
Jazz Pharmaceuticals to Present Xywav Narcolepsy Data at 2026 AAN Annual Meeting - Sleep Review
Eisai Begins Enrolling Phase 2 Study for Narcolepsy Treatment E2086 - Sleep Review
Attention and inhibition deficits in narcolepsy type 1: behavioral and electrophysiological markers - Nature
Surprisingly, Narcolepsy Type 1 Linked to Neurodegeneration Beyond That of Orexin Neurons - Sleep Review
Narcolepsy raises your risk of depression, anxiety and social isolation. Why? - Mayo Clinic Press
After years of exhaustion, a South Philadelphia artist raises awareness for narcolepsy - CBS News
From narcolepsy treatments to symptom management: What to ask your care team - Mayo Clinic Press
Once-Daily Alixorexton Improves Cognition, Fatigue, and Disease Severity in Phase 2 Narcolepsy Type 1 Study - NeurologyLive
Narcolepsy burden especially high for young patients | AMCP Annual 2026 - Managed Healthcare Executive
FDA Grants Orexin Agonist Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1 - NeurologyLive
Narcolepsy Treatment Considerations in Pediatric Patients - NeurologyLive
Alkermes Reports 2025 Financials, Advances Narcolepsy Pipeline, Announces CEO Succession - Sleep Review
Understanding Narcolepsy as More Than a Sleep Disorder - Psychiatric Times
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy - BioWorld News
FDA Expands Indication for Pitolisant to Treat Cataplexy in Pediatric Narcolepsy - NeurologyLive
Bupropion for Treatment of Depression and Narcolepsy in a Postpartum Patient - Psychiatrist.com
Updated diagnostic criteria for narcolepsy type 1 vs. type 2 | AMCP Annual 2026 - Managed Healthcare Executive
FDA Grants Priority Review to Takeda’s Oveporexton for Narcolepsy Type 1 - Sleep Review
Nonprofit aims to bring awareness to for narcolepsy and other sleep disorders - CBS News
Understanding Narcolepsy as More Than a Sleep Disorder - NeurologyLive
Wakix: FDA Expands Approval to Treat Sudden Muscle Weakness in Children With Narcolepsy - WebMD
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug - Yahoo Finance
FDA Grants Breakthrough Therapy Designation to Alixorexton for Narcolepsy Type 1 - HCPLive
Narcolepsy and Mortality Risk: New Data - Medscape
NDA Accepted and Priority Review Granted: Oveporexton for Narcolepsy Type 1 - Psychiatric Times
FDA Accepts New Drug Application for Orexin Agonist Oveporexton in Narcolepsy Type 1, Grants Priority Review - NeurologyLive
Foreign Language Equivalents
Foreign Language Equivalents of 'narcoleptic'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
nnarcoleptic,   narcoleptc,   arcoleptic,   narcloeptic,   narcolepric,   nrcoleptic,   narccoleptic,   nracoleptic,   narocleptic,   narcoletpic,   narcolepticc,   naroleptic,   narcoleptoc,   narcolepptic,   natcoleptic,   narcoeptic,   anrcoleptic,   narrcoleptic,   nacoleptic,   narcooleptic,   narvoleptic,   narcleptic,   narcolepic,   narcoelptic,   narcolepyic,   narco;eptic,   narcoleeptic,   narxoleptic,   naecoleptic,   narcolwptic,   narcolepttic,   narcoleptiv,   nacroleptic,   narcolpetic,   narcolepitc,   narcoleptiic,   narcole[tic,   narcileptic,   narcolptic,   narcolleptic,   narcoleptix,   narcoleptuc,   nsrcoleptic,   narcpleptic,   barcoleptic,   narcolepti,   naarcoleptic,   narcoletic,   narcokeptic,   narcolrptic,   narcoleptci,   marcoleptic,   narcoleotic
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z